Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer.
Loprevite M, Tiseo M, Chiaramondia M, Capelletti M, Bozzetti C, Bortesi B, Naldi N, Nizzoli R, Dadati P, Kunkl A, Zennaro D, Lagrasta C, Campanini N, Spiritelli E, Camisa R, Grossi F, Rindi G, Franciosi V, Ardizzoni A.
Loprevite M, et al. Among authors: lagrasta c.
Clin Cancer Res. 2007 Nov 1;13(21):6518-26. doi: 10.1158/1078-0432.CCR-07-0805.
Clin Cancer Res. 2007.
PMID: 17975165